biotech
A new method allows researchers to increase or decrease the amount of a certain transfer protein inhibitor (BACH1) in cells, which may provide new avenues for cancer research and re-evaluate the effectiveness of protein inhibitors to treat the disease. Led by a team of scientists at Stony Brook University, the study involved modulating BACH1 levels […]
Researchers at the Center for Precision Disease Modeling at the University of Maryland School of Medicine (UMSOM) determined how a specific protein in the SARS-CoV-2 virus that causes COVID-19 damages heart tissue. They then used a drug to reverse the toxic effects of the protein on the heart. Their finding was based on studies of […]
-
Pages
